- Research Grants
Degree in Pharmacy and Biochemistry from Universidade de São Paulo (2005) and Ph.D. in Sciences (Pharmaceutical Production and Control of Medicines) from Universidade de São Paulo (2009); 10+ years of experience in pharmaceutical industry; Accumulated industrial and academic knowledge and experience in Pharmaceutical Research & Development, Manufacturing, Quality Assurance and Quality Control. Assistant Professor of Pharmaceutical Technology at Faculty of Pharmaceutical Sciences of University of São Paulo (2013 to present) ; Key areas of current research interest: Pharmaceutical Technology; Improvement of drug therapies, Solid state chemistry of drugs applied for pharmaceutical formulation design and quality control; Study of polymorphs, nanoparticles, nanocrystals, cocrystals, and amorphous materials; Pharmaceutical Thermal Analysis; Simulation and Modeling for Development of Dosage forms. (Source: Lattes Curriculum)
|News published in Agência FAPESP Newsletter about the researcher|
|Structure of an antitumor agent analyzed with synchrotron light|
Polymorphism, the ability of a substance to crystallize in more than one lattice arrangement, is currently a major concern for the pharmaceutical industry. Albeit the molecule does not change, different packing architectures can lead to significant differences in physicochemical properties that play a key role in the performance of medicines. Thus, in recent years there has been a signi...
Niclosamide is an effective anthelmintic agent that in recent years has been repositioned for use in the treatment of tumors and viral infections. Its low solubility in water, however, may compromise its effective use and performance in preclinical and clinical trials. The present project aims to explore possible alternatives through the research and development of solid dispersions for...
Polymorphism can cause quality deviations during the production of medicines and can influence their effectiveness. Therefore, an understanding of this phenomenon and its implications opens a wide field of possibilities to be explored in the pharmaceutical field, including the emergence of new paradigms and tools for the quality assurance of medicines. Small molecule tyrosine kinase inh...
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
|Data from Web of Science|